← Back to Screener
Inspire Medical Systems, Inc. (INSP)
Price$41.19
Value ScoreA
Growth ScoreB
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-74.82%
Price vs S&P 500 (4W)-6.93%
VGM Score58.78
Market Capitalization$1.19B
P/E Ratio (Annual)8.16x
All Metrics
P/CF (Annual)10.15x
Book Value / Share (Quarterly)$27.51
P/TBV (Annual)8.59x
Revenue Growth (3Y)30.76%
Cash Flow / Share (Quarterly)$3.36
Price vs S&P 500 (YTD)-63.50%
Gross Margin (TTM)85.78%
Net Profit Margin (TTM)14.33%
EPS (TTM)$4.48
10-Day Avg Trading Volume1.13M
EPS Excl Extra (TTM)$4.48
Revenue Growth (5Y)51.20%
EPS (Annual)$4.89
ROI (Annual)18.62%
Gross Margin (Annual)85.39%
Net Profit Margin (5Y Avg)-1.95%
Cash / Share (Quarterly)$9.85
P/E Basic Excl Extra (TTM)9.05x
Revenue Growth QoQ (YoY)1.62%
P/E Normalized (Annual)8.16x
ROA (Last FY)16.03%
Revenue Growth TTM (YoY)8.94%
EBITD / Share (TTM)$2.17
ROE (5Y Avg)-0.94%
Operating Margin (TTM)5.17%
Cash Flow / Share (Annual)$2.75
P/B Ratio1.50x
P/B Ratio (Quarterly)1.87x
Net Income / Employee (Annual)$109,100
EV / Revenue (TTM)1.19x
Net Interest Coverage (TTM)-20.00x
ROA (TTM)15.30%
EPS Growth QoQ (YoY)303.02%
EV / EBITDA (TTM)17.17x
EPS Incl Extra (Annual)$4.89
Current Ratio (Annual)6.08x
Quick Ratio (Quarterly)4.35x
3-Month Avg Trading Volume1.22M
52-Week Price Return-69.68%
EV / Free Cash Flow (Annual)13.86x
P/E Incl Extra (TTM)9.05x
Revenue / Employee (TTM)$686,600
Tangible BV / Share (Quarterly)$18.51
P/S Ratio (Annual)1.30x
Asset Turnover (Annual)1.01x
52-Week High$147.03
Operating Margin (5Y Avg)-5.12%
EPS Excl Extra (Annual)$4.89
CapEx CAGR (5Y)73.34%
Tangible BV CAGR (5Y)226.98%
26-Week Price Return-66.89%
Quick Ratio (Annual)4.46x
13-Week Price Return-34.05%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)6.34x
Enterprise Value$1.09B
Revenue / Share Growth (5Y)47.29%
Asset Turnover (TTM)1.07x
Book Value / Share Growth (5Y)26.38%
Revenue / Employee (Annual)$684,200
Inventory Turnover (Annual)1.18x
Pretax Margin (Annual)7.20%
Cash / Share (Annual)$10.79
3-Month Return Std Dev53.17%
Gross Margin (5Y Avg)84.82%
Net Income / Employee (TTM)$98,400
ROE (Last FY)18.62%
Net Interest Coverage (Annual)-24.65x
EPS Basic Excl Extra (Annual)$4.89
P/FCF (TTM)11.52x
Receivables Turnover (TTM)9.26x
EV / Free Cash Flow (TTM)11.25x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$4.48
Receivables Turnover (Annual)8.57x
ROI (TTM)17.98%
P/S Ratio (TTM)1.30x
Pretax Margin (5Y Avg)-3.51%
Revenue / Share (Annual)$30.65
Tangible BV / Share (Annual)$17.10
Forward P/E45.91x
Price vs S&P 500 (52W)-94.05%
P/E Ratio (TTM)9.05x
EPS Growth TTM (YoY)105.41%
Year-to-Date Return-55.34%
5-Day Price Return0.86%
EPS Normalized (Annual)$4.89
ROA (5Y Avg)-0.53%
Net Profit Margin (Annual)15.95%
Month-to-Date Return-0.41%
Cash Flow / Share (TTM)$-1.03
EBITD / Share (Annual)$2.05
Operating Margin (Annual)5.15%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)8.69x
ROI (5Y Avg)-0.58%
P/E Excl Extra (TTM)9.05x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$4.48
P/TBV (Quarterly)7.83x
P/B Ratio (Annual)3.43x
Inventory Turnover (TTM)0.98x
Pretax Margin (TTM)6.99%
Book Value / Share (Annual)$27.33
Price vs S&P 500 (13W)-42.31%
Beta0.72x
P/FCF (Annual)15.12x
Revenue / Share (TTM)$31.89
ROE (TTM)17.98%
52-Week Low$38.91
vGradeA
gGradeB
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.39est. -0.28
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.84
3.68
3.60
3.60
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
INSPInspire Medical Systems, Inc. | A | B | D | $41.19 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
Inspire Medical Systems develops and commercializes the Inspire system, a minimally invasive neurostimulation technology for treating moderate to severe obstructive sleep apnea. The company distributes its product through hospitals and ambulatory surgery centers, with the majority of revenue derived from the United States market and growing operations in Europe and the Asia Pacific region.